Temat: "INFLUENZA A virus, H1N1 subtype" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Antigenic drift and immunity gap explain reduction in protective responses against influenza A(H1N1)pdm09 and A(H3N2) viruses during the COVID-19 pandemic: a cross-sectional study of human sera collected in 2019, 2021, 2022, and 2023.
Autorzy:: Fossum E; Division of Infection Control, Department of Virology, Norwegian Institute of Public Health, PO Box 222 Skøyen, 0213, Oslo, Norway. .
Rohringer A; Division of Infection Control, Department of Virology, Norwegian Institute of Public Health, PO Box 222 Skøyen, 0213, Oslo, Norway.
Aune T; Division of Infection Control, Department of Virology, Norwegian Institute of Public Health, PO Box 222 Skøyen, 0213, Oslo, Norway.
Rydland KM; Division of Infection Control, Department of Vaccines, Norwegian Institute of Public Health, PO Box 222 Skøyen, 0213, Oslo, Norway.
Bragstad K; Division of Infection Control, Department of Virology, Norwegian Institute of Public Health, PO Box 222 Skøyen, 0213, Oslo, Norway.
Hungnes O; Division of Infection Control, Department of Virology, Norwegian Institute of Public Health, PO Box 222 Skøyen, 0213, Oslo, Norway.; Pokaż więcej
Źródło:: Virology journal [Virol J] 2024 Mar 06; Vol. 21 (1), pp. 57. Date of Electronic Publication: 2024 Mar 06.
Typ publikacji:: Journal Article
MeSH Terms:: Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Influenza A Virus, H1N1 Subtype*
COVID-19*/epidemiology
Child ; Humans ; Cross-Sectional Studies ; Antigenic Drift and Shift ; Influenza A Virus, H3N2 Subtype ; Pandemics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Impact of the H274Y Substitution on N1, N4, N5, and N8 Neuraminidase Enzymatic Properties and Expression in Reverse Genetic Influenza A Viruses.
Autorzy:: Gaymard A; Virpath Unit, CIRI, Inserm U1111, CNRS, UMR5308, ENS Lyon, Université Claude Bernard Lyon 1, F-69372 Lyon, France.; Centre National de Référence des Virus des Infections Respiratoires, Groupement Hospitalier Nord, Hospices Civils de Lyon, F-69317 Lyon CEDEX 04, France.
Picard C; Virpath Unit, CIRI, Inserm U1111, CNRS, UMR5308, ENS Lyon, Université Claude Bernard Lyon 1, F-69372 Lyon, France.
Vazzoler G; Virpath Unit, CIRI, Inserm U1111, CNRS, UMR5308, ENS Lyon, Université Claude Bernard Lyon 1, F-69372 Lyon, France.
Massin P; Avian and Rabbit Virology Immunology and Parasitology Unit, National Reference Laboratory for Avian Influenza, Anses, Ploufragan-Plouzané-Niort Laboratory, BP53, F-22440 Ploufragan, France.
Frobert E; Virpath Unit, CIRI, Inserm U1111, CNRS, UMR5308, ENS Lyon, Université Claude Bernard Lyon 1, F-69372 Lyon, France.; Centre National de Référence des Virus des Infections Respiratoires, Groupement Hospitalier Nord, Hospices Civils de Lyon, F-69317 Lyon CEDEX 04, France.
Sabatier M; Virpath Unit, CIRI, Inserm U1111, CNRS, UMR5308, ENS Lyon, Université Claude Bernard Lyon 1, F-69372 Lyon, France.
Barthelemy M; Virpath Unit, CIRI, Inserm U1111, CNRS, UMR5308, ENS Lyon, Université Claude Bernard Lyon 1, F-69372 Lyon, France.
Valette M; Centre National de Référence des Virus des Infections Respiratoires, Groupement Hospitalier Nord, Hospices Civils de Lyon, F-69317 Lyon CEDEX 04, France.
Ottmann M; Virpath Unit, CIRI, Inserm U1111, CNRS, UMR5308, ENS Lyon, Université Claude Bernard Lyon 1, F-69372 Lyon, France.
Casalegno JS; Virpath Unit, CIRI, Inserm U1111, CNRS, UMR5308, ENS Lyon, Université Claude Bernard Lyon 1, F-69372 Lyon, France.; Centre National de Référence des Virus des Infections Respiratoires, Groupement Hospitalier Nord, Hospices Civils de Lyon, F-69317 Lyon CEDEX 04, France.
Lina B; Virpath Unit, CIRI, Inserm U1111, CNRS, UMR5308, ENS Lyon, Université Claude Bernard Lyon 1, F-69372 Lyon, France.; Centre National de Référence des Virus des Infections Respiratoires, Groupement Hospitalier Nord, Hospices Civils de Lyon, F-69317 Lyon CEDEX 04, France.
Escuret V; Virpath Unit, CIRI, Inserm U1111, CNRS, UMR5308, ENS Lyon, Université Claude Bernard Lyon 1, F-69372 Lyon, France.; Centre National de Référence des Virus des Infections Respiratoires, Groupement Hospitalier Nord, Hospices Civils de Lyon, F-69317 Lyon CEDEX 04, France.; Pokaż więcej
Źródło:: Viruses [Viruses] 2024 Mar 01; Vol. 16 (3). Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:: Journal Article
MeSH Terms:: Influenza A virus*/genetics
Influenza A Virus, H1N1 Subtype*/genetics
Influenza, Human*
Humans ; Oseltamivir/pharmacology ; Antiviral Agents/pharmacology ; Neuraminidase/genetics ; Neuraminidase/metabolism ; Reverse Genetics ; Drug Resistance, Viral/genetics ; Amino Acid Substitution ; Enzyme Inhibitors/pharmacology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Cytotoxic and antiviral activities of Jatropha variegata and Jatropha spinosa in relation to their metabolite profile.
Autorzy:: Shari K; Pharmacognosy Department, Faculty of Pharmacy, Cairo University, Kasr El Aini St, Cairo, 11562, Egypt.
Mohamed OG; Pharmacognosy Department, Faculty of Pharmacy, Cairo University, Kasr El Aini St, Cairo, 11562, Egypt.; Natural Products Discovery Core, Life Sciences Institute, University of Michigan, Ann Arbor, MI, 48109, USA.
Meselhy KM; Pharmacognosy Department, Faculty of Pharmacy, Cairo University, Kasr El Aini St, Cairo, 11562, Egypt.
Tripathi A; Natural Products Discovery Core, Life Sciences Institute, University of Michigan, Ann Arbor, MI, 48109, USA.; Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, MI, 48109, USA.
Khaleel AE; Pharmacognosy Department, Faculty of Pharmacy, Cairo University, Kasr El Aini St, Cairo, 11562, Egypt.
Abdel-Sattar E; Pharmacognosy Department, Faculty of Pharmacy, Cairo University, Kasr El Aini St, Cairo, 11562, Egypt. .
Gedaily RAE; Pharmacognosy Department, Faculty of Pharmacy, Cairo University, Kasr El Aini St, Cairo, 11562, Egypt.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Feb 28; Vol. 14 (1), pp. 4846. Date of Electronic Publication: 2024 Feb 28.
Typ publikacji:: Journal Article
MeSH Terms:: Jatropha*
Influenza A Virus, H1N1 Subtype*
Antineoplastic Agents*
Humans ; Plant Extracts/pharmacology ; Methylene Chloride ; Flavonoids ; Coumarins ; Antiviral Agents/pharmacology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Analysis of data from two influenza surveillance hospitals in Zhejiang province, China, for the period 2018-2022.
Autorzy:: Wang Y; Huzhou Center for Disease Control and Prevention, Huzhou, Zhejiang, China.
Liu Y; Huzhou Center for Disease Control and Prevention, Huzhou, Zhejiang, China.
Liu G; Huzhou Center for Disease Control and Prevention, Huzhou, Zhejiang, China.
Sun X; Huzhou Center for Disease Control and Prevention, Huzhou, Zhejiang, China.
Zhang Z; Huzhou Center for Disease Control and Prevention, Huzhou, Zhejiang, China.
Shen J; Huzhou Center for Disease Control and Prevention, Huzhou, Zhejiang, China.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Feb 28; Vol. 19 (2), pp. e0299488. Date of Electronic Publication: 2024 Feb 28 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Influenza, Human*/prevention & control
Influenza A Virus, H1N1 Subtype*
COVID-19*/epidemiology
Nucleic Acids*
Child ; Humans ; Influenza A Virus, H3N2 Subtype ; Pandemics ; China/epidemiology ; Seasons ; Hospitals ; Sentinel Surveillance

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Clinical predictors of severe forms of influenza A(H1N1)pdm09 in adults and children during the 2009 epidemic in Brazil.
Autorzy:: Braga JU; Department of Epidemiology, Social Medicine Institute, Rio de Janeiro, Rio de Janeiro, Brazil.; Department of Epidemiology and Quantitative Methods, National School of Public Health, Oswaldo Cruz Foundation, Rio de Janeiro, Rio de Janeiro, Brazil.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Feb 26; Vol. 19 (2), pp. e0291843. Date of Electronic Publication: 2024 Feb 26 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Influenza, Human*
Influenza A Virus, H1N1 Subtype*
Epidemics*
Respiratory Insufficiency*/epidemiology
Adult ; Child ; Pregnancy ; Humans ; Female ; Male ; Brazil/epidemiology ; Intensive Care Units

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Green synthesis of MnO 2 NPs using Arabic gum: assessing its potential antiviral activity against influenza A/H1N1.
Autorzy:: Baghban N; The Persian Gulf Marine Biotechnology Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran.
Momeni S; The Persian Gulf Marine Biotechnology Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran.
Behboudi E; Department of Basic Medical Sciences, Khoy University of Medical Sciences, Khoy, Iran.
Dianat-Moghadam H; Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.; Pediatric Inherited Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Darabi A; The Persian Gulf Tropical Medicine Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran.
Targhi HS; Influenza and Respiratory Viruses Department, Pasteur Institute of Iran, Tehran, Iran.
Keshavarz M; The Persian Gulf Tropical Medicine Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran. .; Pokaż więcej
Źródło:: Virology journal [Virol J] 2024 Feb 23; Vol. 21 (1), pp. 48. Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:: Journal Article
MeSH Terms:: Influenza A Virus, H1N1 Subtype*
Influenza, Human*/drug therapy
Metal Nanoparticles*/chemistry
Humans ; Molecular Docking Simulation ; Manganese Compounds/pharmacology ; Oxides/pharmacology ; Antiviral Agents/pharmacology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Immunogenicity and protective efficacy of a co-formulated two-in-one inactivated whole virus particle COVID-19/influenza vaccine.
Autorzy:: Handabile C; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.; Division of Biologics Development, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Ohno M; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.; Division of Biologics Development, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; One Health Research Center, Hokkaido University, Sapporo, Japan.
Sekiya T; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.; Division of Biologics Development, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Nomura N; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.; Division of Biologics Development, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; Division of International Research Promotion, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Kawakita T; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.; Division of Vaccine Immunology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Kawahara M; Division of Biologics Development, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Endo M; KM Biologics Co. Ltd, Kumamoto, Japan.
Nishimura T; KM Biologics Co. Ltd, Kumamoto, Japan.
Okumura M; KM Biologics Co. Ltd, Kumamoto, Japan.
Toba S; Shionogi Pharmaceutical Research Center, Shionogi & Company, Limited, Toyonaka, Japan.; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Sasaki M; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Orba Y; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Chua BY; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Rowntree LC; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Nguyen THO; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Shingai M; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.; Division of Biologics Development, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; Division of Vaccine Immunology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Sato A; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.; Shionogi Pharmaceutical Research Center, Shionogi & Company, Limited, Toyonaka, Japan.; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Sawa H; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.; One Health Research Center, Hokkaido University, Sapporo, Japan.; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Ogasawara K; Division of Biologics Development, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Kedzierska K; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Kida H; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan. .; Division of Biologics Development, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan. .; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan. .; Division of Vaccine Immunology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Feb 20; Vol. 14 (1), pp. 4204. Date of Electronic Publication: 2024 Feb 20.
Typ publikacji:: Journal Article
MeSH Terms:: Influenza, Human*
Influenza Vaccines*
Influenza A Virus, H1N1 Subtype*
COVID-19*/prevention & control
Animals ; Mice ; Humans ; COVID-19 Vaccines ; Antibodies, Viral ; SARS-CoV-2 ; Vaccination/methods ; Virion ; Immunogenicity, Vaccine

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Differential lung gene expression changes in C57BL/6 and DBA/2 mice carrying an identical functional Mx1 gene reveals crucial differences in the host response.
Autorzy:: Bergmann S; Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, TN, USA.
Brunotte L; Institute of Virology Münster, University of Münster, Von-Esmarch-Straße 56, 48149, Münster, Germany.
Schughart K; Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, TN, USA. .; Institute of Virology Münster, University of Münster, Von-Esmarch-Straße 56, 48149, Münster, Germany. .; Pokaż więcej
Źródło:: BMC genomic data [BMC Genom Data] 2024 Feb 15; Vol. 25 (1), pp. 19. Date of Electronic Publication: 2024 Feb 15.
Typ publikacji:: Journal Article
MeSH Terms:: Influenza, Human*
Influenza A Virus, H1N1 Subtype*/genetics
Orthomyxoviridae Infections*/genetics
Influenza A virus*/genetics
Humans ; Mice ; Animals ; Myxovirus Resistance Proteins/genetics ; Mice, Inbred C57BL ; Mice, Inbred DBA ; Lung ; Immunity, Innate ; Gene Expression

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Hydroxypropyl-Beta Cyclodextrin Barrier Prevents Respiratory Viral Infections: A Preclinical Study.
Autorzy:: Lu A; Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA 90089, USA.
Ebright B; Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA 90089, USA.
Naik A; Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA 90089, USA.
Tan HL; Department of Otorhinolaryngology, Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA 19104, USA.
Cohen NA; Department of Otorhinolaryngology, Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA 19104, USA.; Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA 19104, USA.
Bouteiller JC; Viterbi School of Engineering, University of Southern California, Los Angeles, CA 90007, USA.
Lazzi G; Viterbi School of Engineering, University of Southern California, Los Angeles, CA 90007, USA.; Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA.
Louie SG; Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA 90089, USA.
Humayun MS; Viterbi School of Engineering, University of Southern California, Los Angeles, CA 90007, USA.; Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA.
Asante I; Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA 90089, USA.; Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Feb 08; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 08.
Typ publikacji:: Journal Article
MeSH Terms:: Influenza A Virus, H1N1 Subtype*
Virus Diseases*
Cyclodextrins*
beta-Cyclodextrins*/pharmacology
Humans ; Mice ; Animals ; Antiviral Agents/pharmacology ; Antiviral Agents/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Prior Influenza Infection Mitigates SARS-CoV-2 Disease in Syrian Hamsters.
Autorzy:: Di Pietro C; Department of Pediatrics, Yale School of Medicine, New Haven, CT 06519, USA.
Haberman AM; Department of Immunobiology, Yale School of Medicine, New Haven, CT 06519, USA.
Lindenbach BD; Department of Microbial Pathogenesis, Yale School of Medicine, New Haven, CT 06519, USA.; Department of Comparative Medicine, Yale School of Medicine, New Haven, CT 06519, USA.
Smith PC; Department of Comparative Medicine, Yale School of Medicine, New Haven, CT 06519, USA.
Bruscia EM; Department of Pediatrics, Yale School of Medicine, New Haven, CT 06519, USA.
Allore HG; Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06519, USA.; Department of Biostatistics, Yale School of Public Health, New Haven, CT 06519, USA.
Vander Wyk B; Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06519, USA.
Tyagi A; Department of Genetics, Yale Center for Genome Analysis, New Haven, CT 06519, USA.
Zeiss CJ; Department of Comparative Medicine, Yale School of Medicine, New Haven, CT 06519, USA.; Pokaż więcej
Źródło:: Viruses [Viruses] 2024 Feb 03; Vol. 16 (2). Date of Electronic Publication: 2024 Feb 03.
Typ publikacji:: Journal Article
MeSH Terms:: COVID-19*/pathology
Influenza, Human*/pathology
Influenza A Virus, H1N1 Subtype*
Cricetinae ; Animals ; Humans ; Mesocricetus ; SARS-CoV-2 ; Lung ; Disease Models, Animal

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Assessing depression and anxiety among young adults after epidemics and pandemics: a cross-sectional study in Anyang, China.
Autorzy:: Wang G; Department of New Media Design and Technology, School of the Arts, Universiti Sains Malaysia, 11800, Gelugor, Penang, Malaysia.
Sabran K; Department of New Media Design and Technology, School of the Arts, Universiti Sains Malaysia, 11800, Gelugor, Penang, Malaysia. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Feb 02; Vol. 14 (1), pp. 2759. Date of Electronic Publication: 2024 Feb 02.
Typ publikacji:: Journal Article
MeSH Terms:: COVID-19*/epidemiology
Influenza A Virus, H1N1 Subtype*
Male ; Humans ; Female ; Young Adult ; Cross-Sectional Studies ; Depression/psychology ; Anxiety/psychology ; China/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network.
Autorzy:: Rose AMC; Epiconcept, Paris, France.
Pozo F; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Martínez-Baz I; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Instituto de Salud Pública de Navarra-IdiSNA, Pamplona, Spain.
Mazagatos C; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.
Bossuyt N; Sciensano, Brussels, Belgium.
Cauchi JP; Department for Health Regulation, Health Promotion and Disease Prevention, Msida, Malta.
Petrović G; Croatian Institute of Public Health, Zagreb, Croatia.
Loghin II; St Parascheva Clinical Hospital of Infectious Diseases, Iasi, Romania.
Vaikutyte R; Lithuanian University of Health Sciences, Kaunas, Lithuania.
Buda S; Robert Koch Institute, Berlin, Germany.
Machado A; National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal.
Duffy R; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland.
Oroszi B; Semmelweis University, Budapest, Hungary.
Howard J; Epiconcept, Paris, France.
Echeverria A; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Instituto de Salud Pública de Navarra-IdiSNA, Pamplona, Spain.
Andreu C; Subdirección de Epidemiología, Dirección General de Salud Pública, Servicio Extremeño de Salud, Mérida, Spain.
Barbezange C; Sciensano, Brussels, Belgium.
Džiugytė A; Department for Health Regulation, Health Promotion and Disease Prevention, Msida, Malta.
Nonković D; Teaching Public Health Institute of Split-Dalmatia County, Split, Croatia.
Popescu CP; Dr Victor Babes Clinical Hospital of Infectious and Tropical Diseases, Bucharest, Romania.
Majauskaite F; Institute of Clinical Medicine, Medical Faculty, Vilnius University, Vilnius, Lithuania.
Tolksdorf K; Robert Koch Institute, Berlin, Germany.
Gomez V; National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal.
Domegan L; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland.
Horváth JK; Semmelweis University, Budapest, Hungary.
Castilla J; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Instituto de Salud Pública de Navarra-IdiSNA, Pamplona, Spain.
García M; Dirección General de Salud Pública, Departamento de Sanidad, Gobierno de Aragón, Zaragoza, Spain.
Demuyser T; Department of Microbiology and Infection control, UZ Brussel, Brussels, Belgium.
Borg ML; Department for Health Regulation, Health Promotion and Disease Prevention, Msida, Malta.
Tabain I; Croatian Institute of Public Health, Zagreb, Croatia.
Lazar M; 'Cantacuzino' National Military-Medical Institute for Research and Development, Bucharest, Romania.
Kubiliute I; Institute of Clinical Medicine, Medical Faculty, Vilnius University, Vilnius, Lithuania.
Dürrwald R; Robert Koch Institute, Berlin, Germany.
Guiomar R; National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal.
O'Donnell J; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland.
Kristóf K; Semmelweis University, Budapest, Hungary.
Nicolay N; European Centre for Disease Prevention and Control, Stockholm, Sweden.
Bacci S; European Centre for Disease Prevention and Control, Stockholm, Sweden.
Kissling E; Epiconcept, Paris, France.; Pokaż więcej
Corporate Authors:: VEBIS SARI VE network team
Belgium SARI Surveillance Network (BelsariNet)
Źródło:: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024 Feb; Vol. 18 (2), pp. e13255.
Typ publikacji:: Journal Article
MeSH Terms:: Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Influenza A Virus, H1N1 Subtype*/genetics
Influenza Vaccines*
Pneumonia*
Adult ; Humans ; Seasons ; Influenza A Virus, H3N2 Subtype/genetics ; Case-Control Studies ; Vaccine Efficacy ; Europe/epidemiology ; Hospitalization ; Hospitals ; Vaccination

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Influenza A virus resistance to 4'-fluorouridine coincides with viral attenuation in vitro and in vivo.
Autorzy:: Lieber CM; Center for Translational Antiviral Research, Georgia State University Institute for Biomedical Sciences, Atlanta, Georgia, United States of America.
Kang HJ; Center for Translational Antiviral Research, Georgia State University Institute for Biomedical Sciences, Atlanta, Georgia, United States of America.
Aggarwal M; Center for Translational Antiviral Research, Georgia State University Institute for Biomedical Sciences, Atlanta, Georgia, United States of America.
Lieberman NA; Virology Division, Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, Washington, United States of America.
Sobolik EB; Virology Division, Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, Washington, United States of America.
Yoon JJ; Center for Translational Antiviral Research, Georgia State University Institute for Biomedical Sciences, Atlanta, Georgia, United States of America.
Natchus MG; Emory Institute for Drug Development, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Cox RM; Center for Translational Antiviral Research, Georgia State University Institute for Biomedical Sciences, Atlanta, Georgia, United States of America.
Greninger AL; Virology Division, Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, Washington, United States of America.
Plemper RK; Center for Translational Antiviral Research, Georgia State University Institute for Biomedical Sciences, Atlanta, Georgia, United States of America.; Pokaż więcej
Źródło:: PLoS pathogens [PLoS Pathog] 2024 Feb 01; Vol. 20 (2), pp. e1011993. Date of Electronic Publication: 2024 Feb 01 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Influenza A virus*/genetics
Influenza, Human*
Influenza A Virus, H1N1 Subtype*/genetics
Orthomyxoviridae Infections*/drug therapy
Uracil Nucleotides*
Animals ; Mice ; Humans ; Antiviral Agents/therapeutic use ; Ferrets

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Genomic Analysis of Influenza A and B Viruses Carrying Baloxavir Resistance-Associated Substitutions Serially Passaged in Human Epithelial Cells.
Autorzy:: Hickerson BT; Division of Biotechnology Review and Research II, Food and Drug Administration, Silver Spring, MD 20993, USA.
Huang BK; Division of Biotechnology Review and Research II, Food and Drug Administration, Silver Spring, MD 20993, USA.
Petrovskaya SN; Division of Biotechnology Review and Research III, Food and Drug Administration, Silver Spring, MD 20993, USA.
Ilyushina NA; Division of Biotechnology Review and Research II, Food and Drug Administration, Silver Spring, MD 20993, USA.; Pokaż więcej
Źródło:: Viruses [Viruses] 2023 Dec 16; Vol. 15 (12). Date of Electronic Publication: 2023 Dec 16.
Typ publikacji:: Journal Article
MeSH Terms:: Influenza, Human*
Herpesvirus 1, Cercopithecine*
Influenza A Virus, H1N1 Subtype*/genetics
Influenza A Virus, H1N1 Subtype*/metabolism
Thiepins*/pharmacology
Humans ; Oxazines/pharmacology ; Pyridines/pharmacology ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/metabolism ; Antiviral Agents/pharmacology ; Antiviral Agents/therapeutic use ; Epithelial Cells/metabolism ; Genomics ; Viral Proteins/genetics ; Nucleotidyltransferases

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Hypoxia and Activation of Neutrophil Degranulation-Related Genes in the Peripheral Blood of COVID-19 Patients.
Autorzy:: Lei H; CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences, and China National Center for Bioinformation, Beijing 100101, China.; Cunji Medical School, University of Chinese Academy of Sciences, Beijing 101408, China.; Center of Alzheimer's Disease, Beijing Institute for Brain Disorders, Beijing 100069, China.; Pokaż więcej
Źródło:: Viruses [Viruses] 2024 Jan 28; Vol. 16 (2). Date of Electronic Publication: 2024 Jan 28.
Typ publikacji:: Historical Article; Journal Article
MeSH Terms:: COVID-19*/metabolism
Influenza A Virus, H1N1 Subtype*
Influenza Pandemic, 1918-1919*
History, 20th Century ; Humans ; Neutrophils ; Hypoxia/metabolism ; Inflammation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: A novel film spray containing curcumin inhibits SARS-CoV-2 and influenza virus infection and enhances mucosal immunity.
Autorzy:: Nittayananta W; Faculty of Dentistry, Thammasat University, Pathum Thani, Thailand. .
Lerdsamran H; Center for Research Innovation and Biomedical Informatics, Faculty of Medical Technology, Mahidol University, Nakhon Pathom, Thailand.
Chutiwitoonchai N; National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Pathum Thani, Thailand.
Promsong A; Faculty of Medicine, Princess of Naradhiwas University, Narathiwat, Thailand.
Srichana T; Drug Delivery System Excellence Center, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat Yai, Songkhla, Thailand.; Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
Netsomboon K; Faculty of Pharmacy, Thammasat University, Pathum Thani, Thailand.
Prasertsopon J; Center for Research Innovation and Biomedical Informatics, Faculty of Medical Technology, Mahidol University, Nakhon Pathom, Thailand.
Kerdto J; Thammasat Hospital, Thammasat University, Pathum Thani, Thailand.; Pokaż więcej
Źródło:: Virology journal [Virol J] 2024 Jan 23; Vol. 21 (1), pp. 26. Date of Electronic Publication: 2024 Jan 23.
Typ publikacji:: Journal Article
MeSH Terms:: Influenza, Human*
Curcumin*
Influenza A Virus, H1N1 Subtype*
COVID-19*
Orthomyxoviridae Infections*
Animals ; Dogs ; Humans ; SARS-CoV-2 ; Immunity, Mucosal ; Influenza A Virus, H3N2 Subtype ; Madin Darby Canine Kidney Cells ; Antiviral Agents

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Comparison of geological clusters between influenza and COVID-19 in Thailand with unsupervised clustering analysis.
Autorzy:: Methiyothin T; Department of Data-Centric Problem Solving Research, Infectious Disease AI Team, Korea Institute of Science and Technology Information, Yuseong-gu, Daejeon, Republic of Korea.; Department of Applied AI, University of Science & Technology, Yuseong-gu, Daejeon, Republic of Korea.
Ahn I; Department of Data-Centric Problem Solving Research, Infectious Disease AI Team, Korea Institute of Science and Technology Information, Yuseong-gu, Daejeon, Republic of Korea.; Department of Applied AI, University of Science & Technology, Yuseong-gu, Daejeon, Republic of Korea.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Jan 22; Vol. 19 (1), pp. e0296888. Date of Electronic Publication: 2024 Jan 22 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Influenza, Human*/epidemiology
Influenza A Virus, H1N1 Subtype*
COVID-19*/epidemiology
Humans ; Thailand/epidemiology ; Cluster Analysis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Post-marketing active surveillance of Guillain Barré Syndrome following COVID-19 vaccination in persons aged ≥12 years in Italy: A multi-database self-controlled case series study.
Autorzy:: Morciano C; Pharmacoepidemiology and Pharmacosurveillance Unit, National Centre for Drug Research and Evaluation, Istituto Superiore di Sanità (National Institute of Health), Rome, Italy.
Spila Alegiani S; Pharmacoepidemiology and Pharmacosurveillance Unit, National Centre for Drug Research and Evaluation, Istituto Superiore di Sanità (National Institute of Health), Rome, Italy.
Menniti Ippolito F; Pharmacoepidemiology and Pharmacosurveillance Unit, National Centre for Drug Research and Evaluation, Istituto Superiore di Sanità (National Institute of Health), Rome, Italy.
Belleudi V; Department of Epidemiology ASL Roma 1, Lazio Regional Health Service, Rome, Italy.
Trifirò G; Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Zanoni G; Immunology Unit, University Hospital, Verona, Italy.
Puccini A; Hospital Assistance Service, General Directorate for Personal Care, Health and Welfare, Emilia-Romagna Region, Bologna, Italy.
Sapigni E; Hospital Assistance Service, General Directorate for Personal Care, Health and Welfare, Emilia-Romagna Region, Bologna, Italy.
Mores N; Institute of Pharmacology, Pharmacovigilance, Policlinico Universitario A. Gemelli, Catholic University of Sacred Heart, Rome, Italy.
Leoni O; Department of Health of Lombardy Region, Epidemiology Observatory, Milan, Italy.
Monaco G; Department of Health of Lombardy Region, Epidemiology Observatory, Milan, Italy.
Clagnan E; Regional Health Authority, Friuli Venezia Giulia Region, Udine, Italy.
Zappetti C; Central Directorate for Health, Social Policies, Friuli Venezia Giulia Region, Trieste, Italy.
Bovo E; Veneto Tumour Registry, Azienda Zero, Padova, Italy.
Cutillo M; Pharmacoepidemiology and Pharmacosurveillance Unit, National Centre for Drug Research and Evaluation, Istituto Superiore di Sanità (National Institute of Health), Rome, Italy.
Da Cas R; Pharmacoepidemiology and Pharmacosurveillance Unit, National Centre for Drug Research and Evaluation, Istituto Superiore di Sanità (National Institute of Health), Rome, Italy.
Massari M; Pharmacoepidemiology and Pharmacosurveillance Unit, National Centre for Drug Research and Evaluation, Istituto Superiore di Sanità (National Institute of Health), Rome, Italy.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Jan 19; Vol. 19 (1), pp. e0290879. Date of Electronic Publication: 2024 Jan 19 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Influenza Vaccines*
Influenza, Human*/prevention & control
Guillain-Barre Syndrome*/epidemiology
Guillain-Barre Syndrome*/etiology
Influenza A Virus, H1N1 Subtype*
COVID-19*/epidemiology
COVID-19*/prevention & control
COVID-19*/complications
Humans ; COVID-19 Vaccines/adverse effects ; 2019-nCoV Vaccine mRNA-1273 ; BNT162 Vaccine ; ChAdOx1 nCoV-19 ; Ad26COVS1 ; Watchful Waiting ; Italy/epidemiology ; Vaccination/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Multivalent next generation influenza virus vaccines protect against seasonal and pre-pandemic viruses.
Autorzy:: Uno N; Center for Vaccines and Immunology, University of Georgia, Athens, GA, USA.; Department of Infection Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Ross TM; Center for Vaccines and Immunology, University of Georgia, Athens, GA, USA. .; Department of Infectious Diseases, University of Georgia, Athens, GA, USA. .; Florida Research and Innovation Center, Cleveland Clinic Florida, 9801 SW Discovery Way, Port Saint Lucie, FL, 34986, USA. .; Department of Infection Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Jan 16; Vol. 14 (1), pp. 1440. Date of Electronic Publication: 2024 Jan 16.
Typ publikacji:: Journal Article
MeSH Terms:: Influenza Vaccines*
Orthomyxoviridae Infections*
Influenza, Human*
Influenza A Virus, H1N1 Subtype*
Animals ; Mice ; Humans ; Seasons ; Pandemics ; Antibodies, Viral ; Antigens, Viral ; Hemagglutinin Glycoproteins, Influenza Virus

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study.
Autorzy:: Maurel M; Epiconcept Paris France.
Pozo F; National Centre for Microbiology Institute of Health Carlos III Madrid Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP) Madrid Spain.
Pérez-Gimeno G; National Centre for Microbiology Institute of Health Carlos III Madrid Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP) Madrid Spain.
Buda S; Department for Infectious Disease Epidemiology, Respiratory Infections Unit Robert Koch Institute Berlin Germany.
Sève N; Sorbonne Université INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136) Paris France.
Oroszi B; National Laboratory for Health Security, Epidemiology and Surveillance Centre Semmelweis University Budapest Hungary.
Hooiveld M; Nivel Utrecht the Netherlands.
Gomez V; Instituto Nacional de Saúde Dr. Ricardo Jorge Lisbon Portugal.
Domegan L; HSE-Health Protection Surveillance Centre Dublin Ireland.
Martínez-Baz I; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP) Madrid Spain.; Instituto de Salud Pública de Navarra (IdiSNA) Pamplona Spain.
Ilić M; Croatian Institute of Public Health Zagreb Croatia.
Carnahan AS; The Public Health Agency of Sweden (PHAS) Stockholm Sweden.
Mihai ME; 'Cantacuzino' National Military Medical Institute for Research and Development Bucharest Romania.
Martínez A; Subdirección General de Vigilancia y Respuesta a Emergencias de Salud Pública, Agencia de Salud Pública de Catalunya Barcelona Spain.
Goerlitz L; Department for Infectious Disease Epidemiology, Respiratory Infections Unit Robert Koch Institute Berlin Germany.
Enouf V; Centre National de Référence Virus des Infections Respiratoire (CNR VIR), Institut Pasteur Paris France.
Horváth JK; National Laboratory for Health Security, Epidemiology and Surveillance Centre Semmelweis University Budapest Hungary.
Dijkstra F; National Institute for Public Health and the Environment (RIVM) Bilthoven the Netherlands.
Rodrigues AP; Instituto Nacional de Saúde Dr. Ricardo Jorge Lisbon Portugal.
Bennett C; National Virus Reference Laboratory University College Dublin Dublin Ireland.
Trobajo-Sanmartín C; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP) Madrid Spain.; Instituto de Salud Pública de Navarra (IdiSNA) Pamplona Spain.
Mlinarić I; Croatian Institute of Public Health Zagreb Croatia.
Latorre-Margalef N; The Public Health Agency of Sweden (PHAS) Stockholm Sweden.
Ivanciuc A; 'Cantacuzino' National Military Medical Institute for Research and Development Bucharest Romania.
Lopez A; Subdirección General de Epidemiologia y Vigilancia de la Salud Valencia Spain.
Dürrwald R; National Reference Centre for Influenza Robert Koch Institute Berlin Germany.
Falchi A; Laboratoire de Virologie Université de Corse-Inserm Corte France.
Túri G; National Laboratory for Health Security, Epidemiology and Surveillance Centre Semmelweis University Budapest Hungary.
Meijer A; National Institute for Public Health and the Environment (RIVM) Bilthoven the Netherlands.
Melo A; Instituto Nacional de Saúde Dr. Ricardo Jorge Lisbon Portugal.
O'Donnell J; HSE-Health Protection Surveillance Centre Dublin Ireland.
Castilla J; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP) Madrid Spain.; Instituto de Salud Pública de Navarra (IdiSNA) Pamplona Spain.
Vučina VV; Croatian Institute of Public Health Zagreb Croatia.
Hagey TS; The Public Health Agency of Sweden (PHAS) Stockholm Sweden.
Lazar M; 'Cantacuzino' National Military Medical Institute for Research and Development Bucharest Romania.
Kaczmarek M; European Centre for Disease Prevention and Control Stockholm Sweden.
Bacci S; European Centre for Disease Prevention and Control Stockholm Sweden.
Kissling E; Epiconcept Paris France.; Pokaż więcej
Corporate Authors:: VEBIS study team
Źródło:: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024 Jan 10; Vol. 18 (1), pp. e13243. Date of Electronic Publication: 2024 Jan 10 (Print Publication: 2024).
Typ publikacji:: Multicenter Study; Journal Article
MeSH Terms:: Influenza A virus*
Influenza A Virus, H1N1 Subtype*/genetics
Influenza Vaccines*
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Child ; Humans ; Europe/epidemiology ; Influenza A Virus, H3N2 Subtype/genetics ; Primary Health Care ; Vaccine Efficacy ; Infant, Newborn ; Infant ; Child, Preschool ; Adolescent ; Young Adult ; Adult ; Middle Aged

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""INFLUENZA A virus, H1N1 subtype"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji